Logo image of NTNX

NUTANIX INC - A (NTNX) Stock Fundamental Analysis

NASDAQ:NTNX - US67059N1081 - Common Stock

67.21 USD
+1.15 (+1.74%)
Last: 8/29/2025, 8:00:01 PM
66.8499 USD
-0.36 (-0.54%)
After Hours: 8/29/2025, 8:00:01 PM
Fundamental Rating

4

Overall NTNX gets a fundamental rating of 4 out of 10. We evaluated NTNX against 280 industry peers in the Software industry. NTNX has only an average score on both its financial health and profitability. While showing a medium growth rate, NTNX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

NTNX had positive earnings in the past year.
In the past year NTNX had a positive cash flow from operations.
In the past 5 years NTNX reported 4 times negative net income.
Of the past 5 years NTNX 4 years had a positive operating cash flow.
NTNX Yearly Net Income VS EBIT VS OCF VS FCFNTNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

NTNX has a better Return On Assets (0.76%) than 63.57% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.72%, NTNX is in the better half of the industry, outperforming 75.36% of the companies in the same industry.
Industry RankSector Rank
ROA 0.76%
ROE N/A
ROIC 6.72%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NTNX Yearly ROA, ROE, ROICNTNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200

1.3 Margins

NTNX has a Profit Margin of 0.97%. This is in the better half of the industry: NTNX outperforms 63.93% of its industry peers.
NTNX's Operating Margin of 5.63% is fine compared to the rest of the industry. NTNX outperforms 69.29% of its industry peers.
With an excellent Gross Margin value of 86.36%, NTNX belongs to the best of the industry, outperforming 94.29% of the companies in the same industry.
NTNX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.63%
PM (TTM) 0.97%
GM 86.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y2.14%
NTNX Yearly Profit, Operating, Gross MarginsNTNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NTNX is destroying value.
There is no outstanding debt for NTNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NTNX Yearly Shares OutstandingNTNX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
NTNX Yearly Total Debt VS Total AssetsNTNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

NTNX has an Altman-Z score of 2.00. This is not the best score and indicates that NTNX is in the grey zone with still only limited risk for bankruptcy at the moment.
NTNX has a Altman-Z score of 2.00. This is comparable to the rest of the industry: NTNX outperforms 48.21% of its industry peers.
The Debt to FCF ratio of NTNX is 1.76, which is an excellent value as it means it would take NTNX, only 1.76 years of fcf income to pay off all of its debts.
NTNX has a Debt to FCF ratio of 1.76. This is in the better half of the industry: NTNX outperforms 68.21% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.76
Altman-Z 2
ROIC/WACC0.6
WACC11.28%
NTNX Yearly LT Debt VS Equity VS FCFNTNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

2.3 Liquidity

NTNX has a Current Ratio of 1.88. This is a normal value and indicates that NTNX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.88, NTNX is in line with its industry, outperforming 58.93% of the companies in the same industry.
NTNX has a Quick Ratio of 1.88. This is a normal value and indicates that NTNX is financially healthy and should not expect problems in meeting its short term obligations.
NTNX has a Quick ratio (1.88) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
NTNX Yearly Current Assets VS Current LiabilitesNTNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.15% over the past year.
The Revenue has grown by 18.11% in the past year. This is quite good.
NTNX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.18% yearly.
EPS 1Y (TTM)36.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.04%
Revenue 1Y (TTM)18.11%
Revenue growth 3Y17.09%
Revenue growth 5Y14.18%
Sales Q2Q%19.22%

3.2 Future

The Earnings Per Share is expected to grow by 16.42% on average over the next years. This is quite good.
NTNX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.77% yearly.
EPS Next Y9.33%
EPS Next 2Y12.76%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue Next Year15.75%
Revenue Next 2Y15.12%
Revenue Next 3Y15.47%
Revenue Next 5Y19.77%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NTNX Yearly Revenue VS EstimatesNTNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
NTNX Yearly EPS VS EstimatesNTNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 37.97, the valuation of NTNX can be described as expensive.
Based on the Price/Earnings ratio, NTNX is valued a bit cheaper than the industry average as 60.36% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.13, NTNX is valued a bit more expensive.
NTNX is valuated quite expensively with a Price/Forward Earnings ratio of 34.73.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NTNX is on the same level as its industry peers.
NTNX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 37.97
Fwd PE 34.73
NTNX Price Earnings VS Forward Price EarningsNTNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

NTNX's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NTNX indicates a somewhat cheap valuation: NTNX is cheaper than 77.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.5
EV/EBITDA 78.58
NTNX Per share dataNTNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NTNX does not grow enough to justify the current Price/Earnings ratio.
NTNX's earnings are expected to grow with 16.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.07
PEG (5Y)N/A
EPS Next 2Y12.76%
EPS Next 3Y16.42%

0

5. Dividend

5.1 Amount

No dividends for NTNX!.
Industry RankSector Rank
Dividend Yield N/A

NUTANIX INC - A

NASDAQ:NTNX (8/29/2025, 8:00:01 PM)

After market: 66.8499 -0.36 (-0.54%)

67.21

+1.15 (+1.74%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)11-24 2025-11-24/amc
Inst Owners83.21%
Inst Owner Change1.81%
Ins Owners0.29%
Ins Owner Change4.63%
Market Cap18.02B
Analysts82.4
Price Target94.31 (40.32%)
Short Float %2.72%
Short Ratio2.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.68%
Min EPS beat(2)8.38%
Max EPS beat(2)16.99%
EPS beat(4)4
Avg EPS beat(4)22.51%
Min EPS beat(4)8.38%
Max EPS beat(4)32.66%
EPS beat(8)8
Avg EPS beat(8)40.22%
EPS beat(12)12
Avg EPS beat(12)53.91%
EPS beat(16)16
Avg EPS beat(16)55.36%
Revenue beat(2)2
Avg Revenue beat(2)0.04%
Min Revenue beat(2)0%
Max Revenue beat(2)0.07%
Revenue beat(4)4
Avg Revenue beat(4)0.36%
Min Revenue beat(4)0%
Max Revenue beat(4)1.33%
Revenue beat(8)6
Avg Revenue beat(8)0.44%
Revenue beat(12)10
Avg Revenue beat(12)1.44%
Revenue beat(16)12
Avg Revenue beat(16)1.43%
PT rev (1m)0.53%
PT rev (3m)5.42%
EPS NQ rev (1m)0.31%
EPS NQ rev (3m)24.22%
EPS NY rev (1m)0.14%
EPS NY rev (3m)6.05%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.62%
Valuation
Industry RankSector Rank
PE 37.97
Fwd PE 34.73
P/S 7.41
P/FCF 23.5
P/OCF 21.28
P/B N/A
P/tB N/A
EV/EBITDA 78.58
EPS(TTM)1.77
EY2.63%
EPS(NY)1.94
Fwd EY2.88%
FCF(TTM)2.86
FCFY4.26%
OCF(TTM)3.16
OCFY4.7%
SpS9.07
BVpS-2.65
TBVpS-3.36
PEG (NY)4.07
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.76%
ROE N/A
ROCE 7.55%
ROIC 6.72%
ROICexc N/A
ROICexgc N/A
OM 5.63%
PM (TTM) 0.97%
GM 86.36%
FCFM 31.52%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y2.14%
F-Score7
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.76
Debt/EBITDA 6.42
Cap/Depr 110.06%
Cap/Sales 3.29%
Interest Coverage 250
Cash Conversion 403.82%
Profit Quality 3246.46%
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z 2
F-Score7
WACC11.28%
ROIC/WACC0.6
Cap/Depr(3y)95.49%
Cap/Depr(5y)80.87%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.04%
EPS Next Y9.33%
EPS Next 2Y12.76%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue 1Y (TTM)18.11%
Revenue growth 3Y17.09%
Revenue growth 5Y14.18%
Sales Q2Q%19.22%
Revenue Next Year15.75%
Revenue Next 2Y15.12%
Revenue Next 3Y15.47%
Revenue Next 5Y19.77%
EBIT growth 1Y2045.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.98%
EBIT Next 3Y30%
EBIT Next 5YN/A
FCF growth 1Y83.01%
FCF growth 3Y244.18%
FCF growth 5YN/A
OCF growth 1Y74.01%
OCF growth 3Y130.02%
OCF growth 5YN/A